Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma
Open Access
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 122 (3), 299-306
- https://doi.org/10.1016/j.thromres.2007.10.009
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic CancerClinical Cancer Research, 2007
- Tissue factor expression as a possible determinant of thromboembolism in ovarian cancerBritish Journal of Cancer, 2007
- Thromboembolism in Hospitalized Neutropenic Cancer PatientsJournal of Clinical Oncology, 2006
- Venous thromboembolism in patients with diffuse large B-cell lymphomaLeukemia & Lymphoma, 2006
- The Epidemiology of Venous ThromboembolismCirculation, 2003
- Beta-Adrenergic BlockersCirculation, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Natural anticoagulants and the liverJournal of Gastroenterology and Hepatology, 1997
- Long interval between HCV infection and development of hepatocellular carcinomaLiver International, 1995
- Deep venous thrombosis and pulmonary artery embolism in high‐grade non Hodgkin's lymphoma: incidence, causes and prognostic relevanceEuropean Journal of Haematology, 1995